BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

253 related articles for article (PubMed ID: 22086914)

  • 1. Generation and functional characterization of knock-in mice harboring the cardiac troponin I-R21C mutation associated with hypertrophic cardiomyopathy.
    Wang Y; Pinto JR; Solis RS; Dweck D; Liang J; Diaz-Perez Z; Ge Y; Walker JW; Potter JD
    J Biol Chem; 2012 Jan; 287(3):2156-67. PubMed ID: 22086914
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Troponin I Mutations R146G and R21C Alter Cardiac Troponin Function, Contractile Properties, and Modulation by Protein Kinase A (PKA)-mediated Phosphorylation.
    Cheng Y; Rao V; Tu AY; Lindert S; Wang D; Oxenford L; McCulloch AD; McCammon JA; Regnier M
    J Biol Chem; 2015 Nov; 290(46):27749-66. PubMed ID: 26391394
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Long term ablation of protein kinase A (PKA)-mediated cardiac troponin I phosphorylation leads to excitation-contraction uncoupling and diastolic dysfunction in a knock-in mouse model of hypertrophic cardiomyopathy.
    Dweck D; Sanchez-Gonzalez MA; Chang AN; Dulce RA; Badger CD; Koutnik AP; Ruiz EL; Griffin B; Liang J; Kabbaj M; Fincham FD; Hare JM; Overton JM; Pinto JR
    J Biol Chem; 2014 Aug; 289(33):23097-23111. PubMed ID: 24973218
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Effects of Cardiac Troponin I Mutation P83S on Contractile Properties and the Modulation by PKA-Mediated Phosphorylation.
    Cheng Y; Lindert S; Oxenford L; Tu AY; McCulloch AD; Regnier M
    J Phys Chem B; 2016 Aug; 120(33):8238-53. PubMed ID: 27150586
    [TBL] [Abstract][Full Text] [Related]  

  • 5. The R21C Mutation in Cardiac Troponin I Imposes Differences in Contractile Force Generation between the Left and Right Ventricles of Knock-In Mice.
    Liang J; Kazmierczak K; Rojas AI; Wang Y; Szczesna-Cordary D
    Biomed Res Int; 2015; 2015():742536. PubMed ID: 25961037
    [TBL] [Abstract][Full Text] [Related]  

  • 6. A mutation in the N-terminus of troponin I that is associated with hypertrophic cardiomyopathy affects the Ca(2+)-sensitivity, phosphorylation kinetics and proteolytic susceptibility of troponin.
    Gomes AV; Harada K; Potter JD
    J Mol Cell Cardiol; 2005 Nov; 39(5):754-65. PubMed ID: 16005017
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Pathogenesis associated with a restrictive cardiomyopathy mutant in cardiac troponin T is due to reduced protein stability and greatly increased myofilament Ca2+ sensitivity.
    Parvatiyar MS; Pinto JR
    Biochim Biophys Acta; 2015 Feb; 1850(2):365-72. PubMed ID: 25450489
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Functional consequences of the mutations in human cardiac troponin I gene found in familial hypertrophic cardiomyopathy.
    Takahashi-Yanaga F; Morimoto S; Harada K; Minakami R; Shiraishi F; Ohta M; Lu QW; Sasaguri T; Ohtsuki I
    J Mol Cell Cardiol; 2001 Dec; 33(12):2095-107. PubMed ID: 11735257
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Distinct sarcomeric substrates are responsible for protein kinase D-mediated regulation of cardiac myofilament Ca2+ sensitivity and cross-bridge cycling.
    Bardswell SC; Cuello F; Rowland AJ; Sadayappan S; Robbins J; Gautel M; Walker JW; Kentish JC; Avkiran M
    J Biol Chem; 2010 Feb; 285(8):5674-82. PubMed ID: 20018870
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Effects of protein kinase C dependent phosphorylation and a familial hypertrophic cardiomyopathy-related mutation of cardiac troponin I on structural transition of troponin C and myofilament activation.
    Kobayashi T; Dong WJ; Burkart EM; Cheung HC; Solaro RJ
    Biochemistry; 2004 May; 43(20):5996-6004. PubMed ID: 15147183
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Restrictive Cardiomyopathy Troponin I R145W Mutation Does Not Perturb Myofilament Length-dependent Activation in Human Cardiac Sarcomeres.
    Dvornikov AV; Smolin N; Zhang M; Martin JL; Robia SL; de Tombe PP
    J Biol Chem; 2016 Oct; 291(41):21817-21828. PubMed ID: 27557662
    [TBL] [Abstract][Full Text] [Related]  

  • 12. AMP-activated protein kinase phosphorylates cardiac troponin I at Ser-150 to increase myofilament calcium sensitivity and blunt PKA-dependent function.
    Nixon BR; Thawornkaiwong A; Jin J; Brundage EA; Little SC; Davis JP; Solaro RJ; Biesiadecki BJ
    J Biol Chem; 2012 Jun; 287(23):19136-47. PubMed ID: 22493448
    [TBL] [Abstract][Full Text] [Related]  

  • 13. New insights into the functional significance of the acidic region of the unique N-terminal extension of cardiac troponin I.
    Henze M; Patrick SE; Hinken A; Scruggs SB; Goldspink P; de Tombe PP; Kobayashi M; Ping P; Kobayashi T; Solaro RJ
    Biochim Biophys Acta; 2013 Apr; 1833(4):823-32. PubMed ID: 22940544
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Phosphorylation of human cardiac troponin I G203S and K206Q linked to familial hypertrophic cardiomyopathy affects actomyosin interaction in different ways.
    Deng Y; Schmidtmann A; Kruse S; Filatov V; Heilmeyer LM; Jaquet K; Thieleczek R
    J Mol Cell Cardiol; 2003 Nov; 35(11):1365-74. PubMed ID: 14596793
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Impact of site-specific phosphorylation of protein kinase A sites Ser23 and Ser24 of cardiac troponin I in human cardiomyocytes.
    Wijnker PJ; Foster DB; Tsao AL; Frazier AH; dos Remedios CG; Murphy AM; Stienen GJ; van der Velden J
    Am J Physiol Heart Circ Physiol; 2013 Jan; 304(2):H260-8. PubMed ID: 23144315
    [TBL] [Abstract][Full Text] [Related]  

  • 16. N-terminal phosphorylation of cardiac troponin-I reduces length-dependent calcium sensitivity of contraction in cardiac muscle.
    Rao VS; Korte FS; Razumova MV; Feest ER; Hsu H; Irving TC; Regnier M; Martyn DA
    J Physiol; 2013 Jan; 591(2):475-90. PubMed ID: 23129792
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Calpain-1-dependent degradation of troponin I mutants found in familial hypertrophic cardiomyopathy.
    Barta J; Tóth A; Jaquet K; Redlich A; Edes I; Papp Z
    Mol Cell Biochem; 2003 Sep; 251(1-2):83-8. PubMed ID: 14575308
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Protein kinase C and A sites on troponin I regulate myofilament Ca2+ sensitivity and ATPase activity in the mouse myocardium.
    Pi Y; Zhang D; Kemnitz KR; Wang H; Walker JW
    J Physiol; 2003 Nov; 552(Pt 3):845-57. PubMed ID: 12923217
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Monophosphorylation of cardiac troponin-I at Ser-23/24 is sufficient to regulate cardiac myofibrillar Ca
    Martin-Garrido A; Biesiadecki BJ; Salhi HE; Shaifta Y; Dos Remedios CG; Ayaz-Guner S; Cai W; Ge Y; Avkiran M; Kentish JC
    J Biol Chem; 2018 Jun; 293(22):8588-8599. PubMed ID: 29669813
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Protein kinase D is a novel mediator of cardiac troponin I phosphorylation and regulates myofilament function.
    Haworth RS; Cuello F; Herron TJ; Franzen G; Kentish JC; Gautel M; Avkiran M
    Circ Res; 2004 Nov; 95(11):1091-9. PubMed ID: 15514163
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 13.